Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy (Q37563441)

21 August 2017

1 reference

title

Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy (English)

1 reference

21 August 2017

0 references

0 references

Jeannina A Smith

1

1 reference

21 August 2017

Carol A Kauffman

series ordinal

2

1 reference

21 August 2017

publication date

1 July 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

69

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

1403-1415

1 reference

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969110-00002

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969110-00002

Tumor necrosis factor-alpha plays a role in host defense against Histoplasma capsulatum

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969110-00002

Blastomycosis in a young African man presenting with a pleural effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969110-00002

Blastomycosis in patients with the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969110-00002

Coccidioidomycosis pneumonia in a nonendemic area associated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969110-00002

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

12 December 2020

Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways

1 reference

12 December 2020

Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis

1 reference

12 December 2020

Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America

1 reference

12 December 2020

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

12 December 2020

Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis

1 reference

12 December 2020

Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area

1 reference

12 December 2020

Coccidioidomycosis in solid organ transplantation

1 reference

12 December 2020

Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Modulation of infection with Histoplasma capsulatum by inhibition of tumor necrosis factor-alpha activity

1 reference

12 December 2020

Induction of tumor necrosis factor alpha by spherules of Coccidioides immitis

1 reference

12 December 2020

Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?

1 reference

12 December 2020

What are the risks of biologic therapy in rheumatoid arthritis? An update on safety.

1 reference

12 December 2020

Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2).

1 reference

12 December 2020

Reactivation of latent granulomatous infections by infliximab

1 reference

12 December 2020

The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TnFalpha therapy

1 reference

12 December 2020

Reactivation of histoplasmosis after treatment with infliximab

1 reference

12 December 2020

Immunological basis for the use of TNFalpha-blocking agents in ankylosing spondylitis and immunological changes during treatment

1 reference

12 December 2020

Diagnosis of blastomycosis.

1 reference

12 December 2020

Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination

1 reference

12 December 2020

Blastomycosis in solid organ transplant recipients

1 reference

12 December 2020

Tumour necrosis factor antagonists: structure, function, and tuberculosis risks

1 reference

12 December 2020

Blastomycosis in the immunocompromised patient.

1 reference

12 December 2020

Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists.

1 reference

12 December 2020

Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host

1 reference

12 December 2020

Antigen assay with the potential to aid in diagnosis of blastomycosis

1 reference

12 December 2020

The prevention of recrudescent coccidioidomycosis after solid organ transplantation

1 reference

12 December 2020

Infections associated with tumor necrosis factor-alpha antagonists

1 reference

12 December 2020

Infections in patients with rheumatoid arthritis treated with biologic agents

1 reference

12 December 2020

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

12 December 2020

Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice

1 reference

12 December 2020

Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis

1 reference

12 December 2020

Histoplasmosis: a clinical and laboratory update

1 reference

12 December 2020

1 reference

12 December 2020

Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America

1 reference

12 December 2020

Regulation of infection with Histoplasma capsulatum by TNFR1 and -2

1 reference

12 December 2020

Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals

1 reference

12 December 2020

Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area

1 reference

12 December 2020

In vitro production of tumor necrosis factor-alpha by adherent human peripheral blood mononuclear cells incubated with killed coccidioidal arthroconidia and spherules.

1 reference

12 December 2020

Blastomycosis in immunocompromised patients

1 reference

12 December 2020

Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms

1 reference

12 December 2020

Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy

1 reference

12 December 2020

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept

1 reference

12 December 2020

Infliximab for hidradenitis suppurativa

1 reference

12 December 2020

Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study

1 reference

12 December 2020

Blastomycosis in Missouri: epidemiology and risk factors for endemic disease

1 reference

12 December 2020

Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay

1 reference

12 December 2020

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

1 reference

12 December 2020

Adalimumab therapy in rheumatoid arthritis

1 reference

12 December 2020

The epidemiology of blastomycosis in Illinois and factors associated with death

1 reference

12 December 2020

Fungal infections complicating tumor necrosis factor alpha blockade therapy.

1 reference

12 December 2020

10.2165/00003495-200969110-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

1002313608

0 references

1 reference